1. Anti‑proliferative and pro‑apoptotic effects of rosemary and constituent terpenoids in a model for the HER‑2‑enriched molecular subtype of clinical breast cancer
   Nitin Telang, 2018, Oncology Letters CrossRef
2. Involvement of breast cancer stem cells in tumor angiogenesis
   Yu Wang et al, 2017, Oncology Letters CrossRef
3. The nutritional herb Epimedium grandiflorum inhibits the growth in a model for the Luminal A molecular subtype of breast cancer
   Nitin T. Telang et al, 2017, Oncology Letters CrossRef
4. 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
   Benjamin Kasten et al, 2018, International Journal of Molecular Sciences CrossRef
5. Growth inhibitory efficacy of natural products in a model for triple negative molecular subtype of clinical breast cancer
   Nitin Telang, 2017, Biomedical Reports CrossRef
6. Stem cell targeted therapeutic approaches for molecular subtypes of clinical breast cancer (Review)
   Nitin Telang, 2019, World Academy of Sciences Journal CrossRef
7. Inhibitory effects of Chinese nutritional herbs in isogenic breast carcinoma cells with modulated estrogen receptor function
   Nitin Telang et al, 2016, Oncology Letters CrossRef
8. Recent Approaches Encompassing the Phenotypic Cell Heterogeneity for Anticancer Drug Efficacy Evaluation
   Aurimas Stulpinas et al, 2020, Tumor Progression and Metastasis CrossRef
9. Changes in Tumor Stem Cell Markers and Epithelial-Mesenchymal Transition Markers in Nonluminal Breast Cancer after Neoadjuvant Chemotherapy and Their Correlation with Contrast-Enhanced Ultrasound
   Xiaoling Leng et al, 2020, BioMed Research International CrossRef
10. From resistance to resilience: Uncovering chemotherapeutic resistance mechanisms; insights from established models
    Nourhan M. Abdelmaksoud et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
11. Growth inhibitory efficacy of Cornus�officinalis in a cell culture model for triple‑negative breast cancer
    Nitin Telang et al, 2019, Oncology Letters CrossRef
12. Targeting drug resistant stem cells in a human epidermal growth factor receptor‑2‑enriched breast cancer model
    Nitin Telang, 2019, World Academy of Sciences Journal CrossRef
13. Anti‑inflammatory drug resistance selects putative cancer stem cells in a cellular model for genetically predisposed colon cancer
    Nitin Telang, 2017, Oncology Letters CrossRef